INTRODUCTION
============

The European Renal Association -- European Dialysis and Transplant Association (ERA-EDTA) Registry's Annual Report describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) within Europe and countries bordering the Mediterranean Sea, based on the data collected via national and regional renal registries \[[@sfz011-B1]\]. The summary of the ERA-EDTA Registry Annual Report, which is published on an annual basis, is intended to provide an overview of the current status of RRT for ESRD in Europe \[[@sfz011-B2]\]. In 2017 and 2018, data for the year 2016 were received from 52 national or regional renal registries in 36 countries covering a general population of 686.9 million people. When leaving out Israel and Tunisia, the remaining countries cover a general population of 677.3 million people, representing 80.5% of the 2016 European general population, which was similar to 2015 (80.3%). A total of 32 national or regional renal registries from 17 countries provided individual patient data, whereas 20 countries or regions provided aggregated data (see Appendix A1). Compared to the 2015 ERA-EDTA Registry Annual Report, there were no differences in country participation.

This summary presents the 2016 incidence and prevalence of RRT, kidney transplantation activity, and the patient and graft survival. A description of the methods used to analyse the data, along with the full results, can be found in the ERA-EDTA Registry 2016 Annual Report \[[@sfz011-B1]\].

On the occasion of the 2018 global focus on kidneys and women's health, this year's annual report contains additional analyses on sex comparisons, a summary of which is also presented in this article.

RESULTS
=======

Incidence of RRT
----------------

In 2016, 83 311 individuals commenced RRT for ESRD, which equated to an overall unadjusted incidence of 121 per million population (pmp; [Table 1](#sfz011-T1){ref-type="table"}). The unadjusted incidence was highest in Greece (251 pmp), Czech Republic (243 pmp) and Portugal (236 pmp), whereas it was lowest in Ukraine (29 pmp) and Russia (59 pmp; [Table 1](#sfz011-T1){ref-type="table"} and [Figures 1](#sfz011-F1){ref-type="fig"} and [2](#sfz011-F2){ref-type="fig"}). Of the patients commencing RRT, 62% were men, 52% were aged ≥65 years and 23% had diabetes mellitus (DM) as their primary renal diagnosis ([Figure 3](#sfz011-F3){ref-type="fig"}). The median age of the patients commencing RRT in all countries and regions combined was 65.8 years, ranging from 51.0 years in Ukraine to 73.8 years in the Dutch-speaking part of Belgium ([Table 1](#sfz011-T1){ref-type="table"}). The majority of patients started RRT with haemodialysis (HD; 84%), while 12% of patients started with peritoneal dialysis (PD) and 4% received a pre-emptive kidney transplant ([Figure 4](#sfz011-F4){ref-type="fig"}). However, the initial treatment modality varied considerably between age groups, as the proportion of patients receiving either PD or a pre-emptive transplant decreased with increasing age. Furthermore, patients with a primary renal diagnosis of DM were less likely to receive a pre-emptive kidney transplant compared with non-diabetic patients (2% versus 6%). Of the incident patients receiving RRT at Day 91 after the start of treatment, the majority (82%) were receiving HD, 13% were receiving PD and 5% were living with a kidney transplant ([Figure 5](#sfz011-F5){ref-type="fig"}). In the first 90 days of treatment, the percentage of patients receiving HD decreased, and this was particularly evident in the younger age groups.

![Incidence of RRT pmp in 2016, at Day 1, by country/region, unadjusted. The incidence for Czech Republic, Poland, Russia, Slovakia and Tunisia (Sfax region) only includes patients receiving dialysis. For Serbia and England (UK), the incidence is underestimated by, respectively, ∼26% and ∼2% (see [Table 1](#sfz011-T1){ref-type="table"}).](sfz011f1){#sfz011-F1}

![Unadjusted (left panel) and adjusted (right panel) incidence of RRT pmp in 2016, at Day 1, by country/region. Registries providing individual patient data are shown as dark bars, and registries providing aggregated data as light bars. Adjustment of incidence was performed by standardizing the rates to the age and gender distribution of the EU27 population \[[@sfz011-B5]\]. The incidence for Czech Republic, Poland, Russia, Slovakia and Tunisia (Sfax region) only includes patients receiving dialysis. For Serbia and England (UK), the incidence is underestimated by, respectively, ∼26% and ∼2% (see [Table 1](#sfz011-T1){ref-type="table"}).](sfz011f2){#sfz011-F2}

![(**A**) Sex, (**B**) age and (**C**) primary renal disease distribution by type of data provided for incident patients accepted for RRT in 2016, at Day 1. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data.](sfz011f3){#sfz011-F3}

![Treatment modality distribution, at Day 1, by (**A**) type of data provided (**B**) age and (**C**) primary renal diagnosis (DM and non-DM) for incident patients accepted for RRT in 2016. Parts (B) and (C) are only based on the data from registries providing individual patient data. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data. Tx, kidney transplant.](sfz011f4){#sfz011-F4}

![Treatment modality distribution, at Day 91, by (**A**) type of data provided, (**B**) age and (**C**) primary renal diagnosis (DM and non-DM) for incident patients accepted for RRT in 2016. Parts (B) and (C) are only based on the data from registries providing individual patient data. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data. Tx, kidney transplant.](sfz011f5){#sfz011-F5}

###### 

Incidence of RRT in 2016 at Day 1, by country/region, for all primary renal diseases combined and DM types 1 and 2, as count (*n*) and unadjusted rate pmp, and the mean and median age at the start of RRT

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \                                                              General population covered by the registry in thousands   Incidence of RRT in 2016, at Day 1                               
  Country/region                                                                                                                                                                            
  ------------------------------------------------------------- --------------------------------------------------------- ------------------------------------ ----- ------ ------ -------- ----
  Albania                                                                                 2860                                            252                   88    52.6   52.2     50     17

  Austria                                                                                 8700                                            1155                  133   64.4   67.3    305     35

  Belarus                                                                                 8172                                            504                   62    53.0   54.0     92     11

  Belgium, Dutch-speaking[^a^](#tblfn2){ref-type="table-fn"}                              6509                                            1214                  187   71.0   73.8    256     39

  Belgium, French-speaking[^a^](#tblfn2){ref-type="table-fn"}                             4822                                            906                   188   67.3   69.3    202     42

  Bosnia and Herzegovina                                                                  3531                                            397                   112   62.2   63.9    131     37

  Bulgaria                                                                                7102                                            1109                  156                  309     44

  Croatia                                                                                 3755                                            675                   180   64.9   66.0    181     48

  Cyprus                                                                                   857                                            165                   193   66.7   69.0     47     55

  Czech Republic[^b^](#tblfn3){ref-type="table-fn"}                                      10 262                                           2496                  243                         

  Denmark                                                                                 5784                                            740                   128   63.3   67.4    192     33

  Estonia                                                                                 1316                                            112                   85    59.7   61.6     19     14

  Finland                                                                                 5495                                            560                   102   60.9   63.8    189     34

  France                                                                                 66 860                                          11 033                 165   67.9   70.6    2566    38

  Georgia                                                                                 3720                                            754                   203   60.4   61.9    187     50

  Greece                                                                                 10 776                                           2702                  251   70.8   73.6    710     66

  Iceland                                                                                  335                                             30                   89    61.7   65.1     5      15

  Israel                                                                                  8545                                            1612                  189   65.1   68.0    805     94

  Italy (6 of 20 regions)                                                                20 921                                           3023                  144   68.8   71.8    522     25

  Latvia                                                                                  1560                                            171                   110   60.3   63.0     26     17

  Lithuania                                                                               2888                                            310                   107   61.8   62.5     52     18

  Macedonia                                                                               2022                                            332                   164   63.7   65.0     84     42

  Norway                                                                                  5235                                            556                   106   63.1   66.5     88     17

  Poland[^b^](#tblfn3){ref-type="table-fn"}                                              38 362                                           5716                  149                  2098    55

  Portugal                                                                               10 358                                           2446                  236                  757     73

  Romania                                                                                19 505                                           3454                  177   62.4   64.5    356     18

  Russia[^b^](#tblfn3){ref-type="table-fn"}                                              143 869                                          8521                  59    54.3   57.0    1491    10

  Serbia[^c^](#tblfn4){ref-type="table-fn"}                                               7058                                            618                   88    62.0   64.6    139     20

  Slovakia[^b^](#tblfn3){ref-type="table-fn"}                                             5435                                            835                   154   64.6   66.0    316     58

  Spain (All regions)                                                                    46 558                                           6600                  142   63.0   67.5    1610    35

  Spain, Andalusia                                                                        8406                                            1133                  135   63.5   66.0    294     35

  Spain, Aragon                                                                           1317                                            165                   125   63.5   67.3     39     30

  Spain, Asturias                                                                         1041                                            188                   181   64.8   66.6     41     39

  Spain, Basque country                                                                   2166                                            284                   131   63.4   65.4     57     26

  Spain, Cantabria[^a^](#tblfn2){ref-type="table-fn"}                                      582                                             59                   101   63.1   67.7     12     21

  Spain, Castile and León[^a^](#tblfn2){ref-type="table-fn"}                              2445                                            308                   126   68.1   71.3     85     35

  Spain, Castile-La Mancha[^a^](#tblfn2){ref-type="table-fn"}                             2045                                            287                   140   66.1   69.1     67     33

  Spain, Catalonia                                                                        7523                                            1260                  167   65.9   68.7    261     35

  Spain, Extremadura                                                                      1088                                            120                   110   65.6   66.6     34     31

  Spain, Galicia                                                                          2715                                            399                   147   66.0   68.7    102     38

  Spain, Community of Madrid                                                              6467                                            870                   135   64.9   67.7    227     35

  Spain, Region of Murcia                                                                 1465                                            202                   138   63.3   65.3     47     32

  Spain, Navarre[^a^](#tblfn2){ref-type="table-fn"}                                        639                                             82                   128   64.7   67.2     21     33

  Spain, Valencian region                                                                 4960                                            858                   173   65.8   68.9    178     36

  Sweden                                                                                  9923                                            1204                  121   64.0   67.9    324     33

  Switzerland                                                                             8373                                            844                   101   63.8   66.6    181     22

  The Netherlands                                                                        16 349                                           1906                  117   64.2   67.4    368     23

  Tunisia, Sfax region[^b^](#tblfn3){ref-type="table-fn"}                                 1213                                            193                   159   60.5   63.0     62     51

  Turkey[^d^](#tblfn5){ref-type="table-fn"}                                              79 815                                          11 169                 140                  787     10

  UK, England[^a^](#tblfn2){ref-type="table-fn"}^,e^                                     55 268                                           6454                  117   62.3   64.4    1618    29

  UK, Northern Ireland[^a^](#tblfn2){ref-type="table-fn"}                                 1862                                            225                   121   62.8   66.4     55     30

  UK, Scotland                                                                            5405                                            571                   106   59.2   61.6    171     32

  UK, Wales[^a^](#tblfn2){ref-type="table-fn"}                                            3113                                            370                   119   64.9   66.5     92     30

  Ukraine                                                                                42 590                                           1246                  29    49.7   51.0    303     7

  All countries                                                                          687 084                                         83 311                 121   63.1   65.8   17 757   29
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

When cells are left empty, the data are unavailable and could not be used for the calculation of the summary data.

Patients \<20 years of age are not reported. The true incidence counts are, therefore, slightly higher than the counts reported here.

Data on incidence include dialysis patients only.

The incidence is underestimated by *∼*29% due to centres not submitting complete data for 2016.

Data on incidence of primary renal disease (DM) is based on 2078 dialysis patients (18.6% of total).

The incidence is underestimated by *∼*2% due to a small number of centres not submitting complete data for 2016.

DM, diabetes mellitus as primary renal disease.

Prevalence of RRT
-----------------

On 31 December 2016, 564 638 individuals were receiving RRT for ESRD ([Table 2](#sfz011-T2){ref-type="table"}), corresponding to an overall unadjusted prevalence of 823 pmp. Again, there was considerable variation between countries, with the highest unadjusted prevalence seen in Portugal (1906 pmp) and the Spanish regions of Catalonia (1399 pmp) and Valencia (1388 pmp; [Table 2](#sfz011-T2){ref-type="table"} and [Figures 6](#sfz011-F6){ref-type="fig"} and [7](#sfz011-F7){ref-type="fig"}). The unadjusted prevalence of RRT was considerably lower in Ukraine (188 pmp) and Belarus (289 pmp). The top five countries with the highest prevalence of RRT have remained the same since 2014. Of the prevalent patients, 60% were men, 42% were aged ≥65 years and 17% had DM as their primary renal diagnosis ([Figure 8](#sfz011-F8){ref-type="fig"}). The median age of prevalent patients receiving RRT in all countries and regions combined was 62.4 years, ranging from 50.7 years in Albania to 68.0 years in Israel ([Table 2](#sfz011-T2){ref-type="table"}). The majority of prevalent patients (58%) were receiving HD, 37% of patients were living with a kidney transplant and only 5% were receiving PD ([Figure 9](#sfz011-F9){ref-type="fig"}). Once again the modality of RRT varied considerably between age groups as the proportion of patients with a kidney transplant decreased with increasing age. For those aged 20--44 years, 66% were living with a kidney transplant, whereas this was only 42% for patients aged 65--74 years. Prevalent patients with a primary renal diagnosis of DM were much less likely to be living with a kidney transplant compared with the patients without DM (28% versus 50%).

![Prevalence of RRT pmp on 31 December 2016 by country/region. The prevalence for Israel only includes patients receiving dialysis. For Romania, Serbia, Switzerland and England (UK), the prevalence is underestimated by, respectively, ∼30, ∼29, ∼6 and ∼1% (see [Table 2](#sfz011-T2){ref-type="table"}).](sfz011f6){#sfz011-F6}

![Unadjusted (left panel) and adjusted (right panel) prevalence of RRT pmp on 31 December 2016 by country/region. Registries providing individual patient data are shown as dark bars, and registries providing aggregated data as light bars. Adjustment of the prevalence was performed by standardizing the prevalence to the age and gender distribution of the EU27 population \[[@sfz011-B5]\]. The prevalence for Israel only includes patients receiving dialysis. For Romania, Serbia, Switzerland and England (UK), the prevalence is underestimated by, respectively, ∼30, ∼29, ∼6 and ∼1% (see [Table 2](#sfz011-T2){ref-type="table"}).](sfz011f7){#sfz011-F7}

![(**A**) Sex, (**B**) age and (**C**) primary renal disease distribution by type of data provided for prevalent patients on RRT on 31 December 2016. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data.](sfz011f8){#sfz011-F8}

![Treatment modality distribution by (**A**) type of data provided (**B**) age and (**C**) primary renal diagnosis (DM and non-DM) for prevalent patients on RRT on 31 December 2016. Parts (B) and (C) are only based on the data from registries providing individual patient data. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data. Tx, kidney transplant.](sfz011f9){#sfz011-F9}

###### 

Prevalence of RRT on 31 December 2016, by country/region, for all primary renal diseases combined and DM types 1 and 2, as count (*n*) and unadjusted rate pmp, and the mean and median age on 31 December 2016

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \                                                              General population covered by the registry in thousands   Prevalent patients on RRT in 2016                                
  Country/region                                                                                                                                                                            
  ------------------------------------------------------------- --------------------------------------------------------- ----------------------------------- ------ ------ ------ -------- -----
  Albania                                                                                 2860                                           1450                  507    49.6   50.7    230     80

  Austria                                                                                 8700                                           9397                  1080   61.2   62.7    1848    212

  Belarus                                                                                 8172                                           2360                  289    51.6   53.0    295     36

  Belgium, Dutch-speaking[^a^](#tblfn9){ref-type="table-fn"}                              6509                                           8257                  1269   66.1   67.9    1426    219

  Belgium, French-speaking[^a^](#tblfn9){ref-type="table-fn"}                             4822                                           6317                  1310   64.9   66.5    1109    230

  Bosnia and Herzegovina                                                                  3531                                           2679                  759    59.7   61.7    548     155

  Bulgaria                                                                                7102                                           4333                  610                          

  Croatia                                                                                 3755                                           3908                  1041   65.7   67.0    710     189

  Cyprus                                                                                   857                                                                                              

  Czech Republic                                                                         10 262                                         11 265                 1098                         

  Denmark                                                                                 5784                                           5433                  939    58.8   60.4    929     161

  Estonia                                                                                 1316                                            919                  698    57.9   58.6    168     128

  Finland                                                                                 5495                                           4861                  885    59.2   61.5    1231    224

  France                                                                                 66 860                                         85 471                 1278   62.8   64.6   13 833   207

  Georgia                                                                                 3720                                           2652                  713    60.1   61.2    539     145

  Greece                                                                                 10 776                                         13 841                 1284   64.6   66.8    2637    245

  Iceland                                                                                  335                                            224                  668    54.9   56.3     26     78

  Israel[^b^](#tblfn10){ref-type="table-fn"}                                              8545                                           6566                  768    66.0   68.0    3035    355

  Italy (6 of 20 regions)                                                                20 921                                         24 035                 1149   62.0   64.1    2654    127

  Latvia                                                                                  1560                                           1038                  665    56.3   57.0     98     63

  Lithuania                                                                               2888                                           2193                  759                          

  Macedonia                                                                               2022                                           1665                  823    58.6   60.0    273     135

  Norway                                                                                  5235                                           4974                  950    59.4   61.5    654     125

  Poland                                                                                 38 362                                         31 144                 812                   6132    160

  Portugal                                                                               10 358                                         19 738                 1906   66.9   67.9    3435    332

  Romania[^c^](#tblfn11){ref-type="table-fn"}                                            19 505                                         20 445                 1048   61.2   63.0    2051    105

  Russia                                                                                1 43 869                                        44 544                 310    55.5   57.0    5340    37

  Serbia[^d^](#tblfn12){ref-type="table-fn"}                                              7058                                           3833                  543    59.5   62.0    640     91

  Slovakia[^b^](#tblfn10){ref-type="table-fn"}                                            5435                                           3370                  620    63.8   66.0    1140    210

  Spain (All regions)                                                                    46 558                                         57 433                 1234   60.0   63.2    9031    194

  Spain, Andalusia                                                                        8406                                          10 019                 1192   60.5   61.9    1548    184

  Spain, Aragon                                                                           1317                                           1588                  1205   62.9   64.0    274     208

  Spain, Asturias                                                                         1041                                           1325                  1273   63.0   63.5    215     207

  Spain, Basque country                                                                   2166                                           2704                  1249   62.0   63.8    304     140

  Spain, Cantabria[^a^](#tblfn9){ref-type="table-fn"}                                      582                                            686                  1179   62.6   64.0     91     156

  Spain, Castile and León[^a^](#tblfn9){ref-type="table-fn"}                              2445                                           2858                  1169   64.8   65.8    505     207

  Spain, Castile-La Mancha[^a^](#tblfn9){ref-type="table-fn"}                             2045                                           2357                  1153   62.5   63.3    373     182

  Spain, Catalonia                                                                        7523                                          10 523                 1399   63.0   64.8    1499    199

  Spain, Community of Madrid                                                              6467                                           7450                  1152   61.9   63.2    1323    205

  Spain, Extremadura                                                                      1088                                           1263                  1161   62.0   62.3    191     176

  Spain, Galicia                                                                          2715                                           3619                  1333   62.5   64.0    598     220

  Spain, Navarre[^a^](#tblfn9){ref-type="table-fn"}                                        639                                            837                  1310   62.5   64.0    128     200

  Spain, Region of Murcia                                                                 1465                                           1949                  1331   62.1   63.3    274     187

  Spain, Valencian region                                                                 4960                                           6883                  1388   63.3   65.2    933     188

  Sweden                                                                                  9923                                           9718                  979    59.9   62.0    1742    176

  Switzerland[^e^](#tblfn13){ref-type="table-fn"}                                         8373                                           7503                  896    62.1   63.9    1159    138

  The Netherlands                                                                        16 349                                         17 117                 1047   60.5   62.4    2229    136

  Tunisia, Sfax region[^b^](#tblfn10){ref-type="table-fn"}                                1213                                            946                  780    58.2   59.0    200     165

  Turkey[^f^](#tblfn14){ref-type="table-fn"}                                             79 815                                         74 475                 933                   2719    34

  UK, England[^a^](#tblfn9){ref-type="table-fn"}^,g^                                     55 268                                         52 641                 952    58.8   59.2    8884    161

  UK, Northern Ireland[^a^](#tblfn9){ref-type="table-fn"}                                 1862                                           1784                  958    58.7   58.4    280     150

  UK, Scotland                                                                            5405                                           5028                  930    56.8   57.7    826     153

  UK, Wales[^a^](#tblfn9){ref-type="table-fn"}                                            3113                                           3062                  984    59.5   60.3    503     162

  Ukraine                                                                                42 590                                          8019                  188    49.5   51.0    1280    30

  All countries                                                                          687 084                                        564 638                823    60.6   62.4   79 834   134
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

When cells are left empty, the data are unavailable and could not be used for the calculation of the summary data.

Patients \<20 years of age are not reported. The true prevalent counts are therefore slightly higher than the counts reported here.

Data on prevalence include dialysis patients only.

The prevalence is underestimated by ∼3% due to an estimated 30% under-reporting of patients living with a functioning graft.

The prevalence is underestimated by *∼*29% due to centres not submitting complete data for 2016.

The prevalence is underestimated by ∼6% due to an estimated 11% under-reporting of patients living with a functioning graft.

Data on the prevalence of primary renal disease (DM) is based on 8043 dialysis patients (10.8% of total)

The prevalence is underestimated by ∼1% due to a small number of centres not submitting complete data for 2016.

DM, diabetes mellitus as primary renal disease.

Kidney transplantation
----------------------

In 2016, 22 046 kidney transplantations were performed, which equated to an overall unadjusted transplant rate of 32 pmp ([Figure 10](#sfz011-F10){ref-type="fig"}). Again there was considerable variation between countries/regions with unadjusted kidney transplant rates well over 70 pmp in several Spanish regions, and very low unadjusted kidney transplant rates in Ukraine (3 pmp) and Macedonia (3 pmp). Overall, the unadjusted deceased donor kidney transplant rate was more than twice that of the unadjusted living donor transplant rate (22 pmp versus 9 pmp; 70% versus 30%; [Figure 11](#sfz011-F11){ref-type="fig"}). The highest unadjusted rates of deceased donor kidney transplants were seen in some Spanish regions (\>70 pmp; [Figure 12](#sfz011-F12){ref-type="fig"}), whereas the highest unadjusted rate of living donor transplants was seen in Northern Ireland (38 pmp), the Netherlands (33 pmp) and Turkey (33 pmp; [Figure 12](#sfz011-F12){ref-type="fig"}).

![Kidney transplants performed in 2016, as counts and pmp (unadjusted) by country/region. Registries providing individual patient data are shown as dark bars, and registries providing aggregated data as light bars. Data based on patients aged ≥20 years in Dutch-speaking Belgium, French-speaking Belgium, the Spanish regions of Cantabria, Castile and León, Castile-La Mancha and Navarre and UK: England, Northern Ireland and Wales. The total count for Austria is based on residents and non-residents. For Romania, Serbia, Switzerland and England (UK), the overall kidney transplant rate is underestimated by, respectively, ∼30, ∼36, ∼6 and ∼7%.](sfz011f10){#sfz011-F10}

![Donor-type distribution for kidney transplants performed in 2016, by type of data provided. See Appendix A1 for a list of countries and regions supplying individual patient data or aggregated data.](sfz011f11){#sfz011-F11}

![Deceased donor (left panel) and living donor (right panel) kidney transplants performed in 2016 pmp, by country/region, unadjusted. Registries providing individual patient data are shown as dark bars, and registries providing aggregated data as light bars. Data based on patients aged ≥20 years in Dutch-speaking Belgium, French-speaking Belgium, the Spanish regions of Cantabria, Castile and León, Castile-La Mancha and Navarre and UK: England, Northern Ireland and Wales. The total count for Austria is based on residents and non-residents. For Romania, Switzerland and England (UK), the kidney transplant rate is underestimated by, respectively, ∼30, ∼6 and ∼7%. For Serbia, the transplant rate is underestimated by ∼29% for deceased donor transplants and by ∼39% for living donor transplants.](sfz011f12){#sfz011-F12}

Survival of patients receiving RRT
----------------------------------

For patients commencing RRT in the period 2007--11, the 5-year unadjusted patient survival probability for all RRT modalities combined was 50.5% \[95% confidence interval (CI) 50.4--50.6\]. For patients commencing RRT with dialysis between 2007 and 2011, the 5-year unadjusted patient survival probability was 42.1% (95% CI 42.0--42.3). Adjusted analyses for patient survival on HD and PD revealed higher survival probabilities in the first 3 years for patients receiving PD ([Figure 13](#sfz011-F13){ref-type="fig"}). For those with a kidney transplant, 5-year adjusted patient and graft survival were higher for living donor transplants compared with deceased donor transplants: 94.6% (95% CI 94.1--95.1) versus 91.9% (95% CI 91.6--92.3) for patient survival and 86.7% (95% CI 85.9--87.4) versus 80.9% (95% CI 80.4--81.4) for graft survival. See [Table 3](#sfz011-T3){ref-type="table"} for a description of the adjustments made and the countries/regions included in these analyses.

![Patient survival of patients starting HD and PD between 2007 and 2011 from Day 91 (left panel) and patients receiving a first kidney transplant from a living or deceased donor between 2007 and 2011 (right panel). Survival on dialysis was censored for transplantation, and adjusted using fixed values for age (67 years), gender (63% men) and primary renal disease (24% DM, 19% hypertension/renal vascular disease, 11% glomerulonephritis and 46% other causes). Survival after kidney transplantation was adjusted using fixed values for age (50 years), gender (63% men) and primary renal disease (14% DM, 10% hypertension/renal vascular disease, 23% glomerulonephritis and 53% other causes). These figures are based on the data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Extremadura), Spain (Galicia), Spain (Community of Madrid), Spain (Valencian region), Sweden, the Netherlands and the UK (all countries).](sfz011f13){#sfz011-F13}

###### 

The survival probabilities at 1, 2 and 5 years by treatment modality and cohort, from Day 1 of the start of RRT/dialysis, or from the day of kidney transplantation

                                                                          Survival probabilities as percentage (95% CI)                                                              
  ---------------------------------------------------------------------- ----------------------------------------------- ------------------- ------------------- ------------------- -------------------
  Patient survival on RRT                                                                                                                                                            
   Unadjusted                                                                           83.6 (83.4--83.7)                 73.2 (73.1--73.4)   50.5 (50.4--50.6)   84.6 (84.4--84.7)   74.6 (74.5--74.8)
   Adjusted[^a^](#tblfn18){ref-type="table-fn"}                                         86.3 (86.1--86.4)                 76.6 (76.4--76.9)   51.7 (51.5--52.0)   87.1 (86.9--87.3)   77.9 (77.7--78.1)
  Patient survival on dialysis                                                                                                                                                       
   Unadjusted                                                                           82.5 (82.4--82.7)                 70.8 (70.6--71.0)   42.1 (42.0--42.3)   83.5 (83.3--83.6)   72.1 (71.9--72.2)
   Adjusted[^a^](#tblfn18){ref-type="table-fn"}                                         84.7 (84.5--84.9)                 74.0 (73.7--74.2)   45.5 (45.2--45.8)   85.9 (85.7--86.0)   75.6 (75.4--75.8)
  Patient survival after first kidney transplantation (deceased donor)                                                                                                               
   Unadjusted                                                                           96.3 (96.1--96.5)                 94.4 (94.1--94.6)   87.7 (87.3--88.0)   96.3 (96.1--96.5)   94.3 (94.0--94.5)
   Adjusted[^b^](#tblfn19){ref-type="table-fn"}                                         97.7 (97.5--97.9)                 96.4 (96.2--96.6)   91.9 (91.6--92.3)   97.9 (97.8--98.1)   96.7 (96.5--96.9)
  Graft survival after first kidney transplantation (deceased donor)                                                                                                                 
   Unadjusted                                                                           91.1 (90.7--91.4)                 88.2 (87.9--88.5)   78.7 (78.3--79.1)   91.0 (90.8--91.3)   88.0 (87.7--88.3)
   Adjusted[^b^](#tblfn19){ref-type="table-fn"}                                         92.1 (91.8--92.4)                 89.6 (89.2--89.9)   80.9 (80.4--81.4)   92.6 (92.3--92.9)   90.0 (89.7--90.4)
  Patient survival after first kidney transplantation (living donor)                                                                                                                 
   Unadjusted                                                                           98.7 (98.4--98.9)                 97.8 (97.4--98.0)   94.1 (93.6--94.5)   99.1 (98.9--99.2)   98.1 (97.9--98.4)
   Adjusted[^b^](#tblfn19){ref-type="table-fn"}                                         98.8 (98.6--99.1)                 98.0 (97.7--98.3)   94.6 (94.1--95.1)   99.2 (99.1--99.4)   98.5 (98.2--98.7)
  Graft survival after first kidney transplantation (living donor)                                                                                                                   
   Unadjusted                                                                           95.9 (95.5--96.3)                 94.1 (93.6--94.5)   87.5 (86.9--88.0)   96.8 (96.5--97.1)   95.1 (94.7--95.4)
   Adjusted[^b^](#tblfn19){ref-type="table-fn"}                                         95.6 (95.2--96.1)                 93.7 (93.2--94.2)   86.7 (85.9--87.4)   96.6 (96.3--97.0)   94.8 (94.4--95.2)

This is based on the data from the following renal registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Extremadura), Spain (Galicia), Spain (Community of Madrid), Spain (Valencian region), Sweden, the Netherlands and the UK (all countries).

Analyses were adjusted using fixed values: age (67 years), gender (63% men) and primary renal disease (24% DM, 19% hypertension/renal vascular disease, 11% glomerulonephritis and 46% other causes).

Analyses were adjusted using fixed values: age (50 years), gender (63% men) and primary renal disease (14% DM, 10% hypertension/renal vascular disease, 23% glomerulonephritis and 53% other causes).

Expected remaining lifetime
---------------------------

There is still a substantial difference in the expected remaining lifetime between the general population and those receiving dialysis ([Figure 14](#sfz011-F14){ref-type="fig"}). Patients aged 20--44 years receiving dialysis are expected to live only one-third of the expected remaining lifetime of the age-matched general population, which is about 33 years less. The prospect is even worse for patients aged 45--64 years, as they are expected to live only a quarter as long as their age-matched counterparts in the general population (*∼*21 years less). Patients living with a kidney transplant fare better than those receiving dialysis. However, the life expectancy of the transplant recipients aged 20--44 years is still ∼30% less than that of the age-matched general population (*∼*15 years less). Thus, as the age of the transplant recipient increases, the relative difference in the expected remaining lifetime from that of the age-matched general population also increases although the absolute difference decreases.

![Expected remaining lifetimes of the general population (cohort 2012--16), and of prevalent dialysis and kidney transplant patients (cohort 2012--16), by age and gender. This figure is based on data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque Country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Extremadura), Spain (Galicia), Spain (Community of Madrid), Spain (Valencian region), Sweden, the Netherlands and the UK (all countries).](sfz011f14){#sfz011-F14}

Sex comparisons
---------------

[Figures 15--31](#sfz011-F15){ref-type="fig"} showing comparisons of the sexes are based on the data from 32 national or regional renal registries from 17 countries that provided individual patient data, representing 33.8% of the 2016 European general population.

![Incidence of RRT per million age-related population (pmarp) in 2016, at Day 1, by age and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f15){#sfz011-F15}

![Age distribution by sex for incident patients accepted for RRT in 2016, at Day 1. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f16){#sfz011-F16}

![Sex distribution by age for incident patients accepted for RRT in 2016, at Day 1. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f17){#sfz011-F17}

![Incidence of RRT pmp in 2016, at Day 1, by primary renal disease and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f18){#sfz011-F18}

![Primary renal disease distribution by sex for incident patients accepted for RRT in 2016, at Day 1. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f19){#sfz011-F19}

![Incidence of RRT pmp in 2016, at Day 1, by treatment modality and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f20){#sfz011-F20}

![Treatment modality distribution by sex for incident patients accepted for RRT in 2016, at Day 1. Figure is only based on the data from registries providing individual patient data (see Appendix A1). Tx, kidney transplant.](sfz011f21){#sfz011-F21}

![Prevalence of RRT pmarp on 31 December 2016, by age and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f22){#sfz011-F22}

![Age distribution by sex for prevalent patients on RRT on 31 December 2016. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f23){#sfz011-F23}

![Sex distribution by age for prevalent patients on RRT on 31 December 2016. Figure is only based on data from registries providing individual patient data (see Appendix A1).](sfz011f24){#sfz011-F24}

![Prevalence of RRT pmp on 31 December 2016, by primary renal disease and sex. Figure is only based on data from registries providing individual patient data (see Appendix A1).](sfz011f25){#sfz011-F25}

![Primary renal disease distribution by sex for prevalent patients on RRT on 31 December 2016. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f26){#sfz011-F26}

![Prevalence of RRT pmp on 31 December 2016, by treatment modality and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f27){#sfz011-F27}

![Treatment modality distribution by sex for prevalent patients on RRT on 31 December 2016. Figure is only based on the data from registries providing individual patient data (see Appendix A1). Tx, kidney transplant.](sfz011f28){#sfz011-F28}

![Kidney transplants performed pmp in 2016, by donor type and sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f29){#sfz011-F29}

![Donor-type distribution for kidney transplants performed in 2016, by sex. Figure is only based on the data from registries providing individual patient data (see Appendix A1).](sfz011f30){#sfz011-F30}

![Patient survival of men and women starting HD and PD between 2007 and 2011 from Day 91 (left panel) and men and women receiving a first kidney transplant from a living or deceased donor between 2007 and 2011 (right panel). Survival on dialysis was adjusted using fixed values for age (67 years) and primary renal disease (24% diabetes mellitus, 19% hypertension/renal vascular disease, 11% glomerulonephritis and 46% other causes). Survival after kidney transplantation was adjusted using fixed values for age (50 years) and primary renal disease (14% diabetes mellitus, 10% hypertension/renal vascular disease, 23% glomerulonephritis and 53% other causes). These figures are based on the data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Extremadura), Spain (Galicia), Spain (Community of Madrid), Spain (Valencian region), Sweden, the Netherlands and the UK (all countries).](sfz011f31){#sfz011-F31}

In 2016, 26 446 men and 14 820 women commenced RRT resulting in a higher unadjusted incidence among men (187 pmp) than women (101 pmp). This was the case for all age groups, with the incidence in men aged ≥75 years (807 pmp) being 2.7 times that of women aged ≥75 years (300 pmp; [Figure 15](#sfz011-F15){ref-type="fig"}). In men and women commencing RRT, the distribution of the age groups was very similar ([Figure 16](#sfz011-F16){ref-type="fig"}). About 36% of patients commencing RRT were female, decreasing from around 39% of patients \<45 years at the start of RRT to about 36% of patients aged ≥45 years ([Figure 17](#sfz011-F17){ref-type="fig"}).

Diabetes was the most frequent primary renal disease in both men and women starting RRT ([Figure 18](#sfz011-F18){ref-type="fig"}). The incidence of men starting RRT for ESRD due to glomerulonephritis/sclerosis (23 pmp) and hypertension (29 pmp) was more than double that of their female counterparts (10 and 13 pmp, respectively), while the incidence of polycystic kidney disease in men (9 pmp) was only about 30% higher than in women (7 pmp). When viewed by sex, the distribution of the primary renal disease was similar. Of the men commencing RRT, 16% had hypertension and 12% had glomerulonephritis/sclerosis, and for women this was 13 and 10%, respectively ([Figure 19](#sfz011-F19){ref-type="fig"}).

The incidence of all treatment modalities was higher among men than women ([Figure 20](#sfz011-F20){ref-type="fig"}). Of the men and women initiating RRT in 2016, the majority started with HD (82 and 81%, respectively; [Figure 21](#sfz011-F21){ref-type="fig"}). Although more men (8 pmp) than women (5 pmp) received a pre-emptive transplant, the percentage of patients starting RRT with a pre-emptive transplant was similar among men (4%) and women (5%).

On 31 December 2016, 195 810 men and 121 755 women were receiving RRT for ESRD, resulting in a higher prevalence of RRT among men (1381 pmp) than women (827 pmp), which was the case for all age groups ([Figure 22](#sfz011-F22){ref-type="fig"}). In men, the highest prevalence was found in the group aged ≥75 years, whereas in women the highest prevalence was found in the group aged 65--74 years. The age distribution of patients receiving RRT was similar for both sexes, with most patients in the 45- to 64-year age group (39%; [Figure 23](#sfz011-F23){ref-type="fig"}). The percentage of women within the different age groups varied between 37% among patients aged 65--74 years and 40% among patients aged 0--19 years ([Figure 24](#sfz011-F24){ref-type="fig"}). The prevalence of men on RRT with glomerulonephritis/sclerosis and hypertension (301 and 167 pmp) was more than twice that of women (140 and 75 pmp; [Figure 25](#sfz011-F25){ref-type="fig"}). For men receiving RRT, the most frequent primary renal disease was glomerulonephritis/sclerosis (22%), while for women their most frequent primary renal disease category was 'miscellaneous' ([Figure 26](#sfz011-F26){ref-type="fig"}, Appendix 2). For both men and women, the majority of patients were receiving HD (668 and 399 pmp), and slightly fewer men and women were living with a kidney transplant (642 and 382 pmp, respectively; [Figure 27](#sfz011-F27){ref-type="fig"}). The distribution of treatment modalities was similar across the sexes ([Figure 28](#sfz011-F28){ref-type="fig"}).

In 2016, 8355 kidney transplantations were performed in men, and 4827 in women, equating to transplant rates of 59 and 33 pmp, respectively ([Figure 29](#sfz011-F29){ref-type="fig"}). For men, 22% of the transplants came from living donors, and for women 24% ([Figure 30](#sfz011-F30){ref-type="fig"}).

For patients commencing RRT with dialysis in the period 2007--11, for both HD and PD, the adjusted patient survival probabilities were higher for women than for men ([Figure 31](#sfz011-F31){ref-type="fig"}). For both men and women receiving a kidney transplant in the period 2007--11, the adjusted patient survival was higher with a living donor transplant compared with a deceased donor transplant, and this difference was more prominent in men than in women.
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Countries or regions providing aggregated data are: Albania, Belarus, Bulgaria, Croatia, Cyprus, Czech Republic, Georgia, Israel, Italy, Latvia, Lithuania, Macedonia, Poland, Portugal, Russia, Slovakia, Spain, Tunisia (Sfax region), Turkey, Ukraine.

Miscellaneous primary renal diseases: Nephropathy (interstitial) due to analgesic drugs, nephropathy (interstitial) due to *cis*-platinum, nephropathy (interstitial) due to cyclosporin A, lead-induced nephropathy (interstitial), drug-induced nephropathy (interstitial) not mentioned above, cystic kidney disease---type unspecified, polycystic kidneys; infantile (recessive), medullary cystic disease; including nephronophtisis, cystic kidney disease---other specified type, hereditary/familial nephropathy---type unspecified, hereditary nephritis with nerve deafness (Alport's Syndrome), cystinosis, primary oxalosis, Fabry's disease, hereditary nephropathy---other specified type, renal hypoplasia (congenital)---type unspecified, oligomeganephronic hypoplasia, congenital renal dysplasia with or without urinary tract malformation, syndrome of agenesis of abdominal muscles (prune belly), renal vascular disease due to polyarteritis, Wegener's granulomatosis, ischaemic renal disease/cholesterol embolism, glomerulonephritis related to liver cirrhosis, cryoglobulinemic glomerulonephritis, myelomatosis/light-chain deposit disease, amyloid, lupus erythematosus, Henoch--Schonlein purpura, Goodpasture's Syndrome, systemic sclerosis (scleroderma), haemolytic uraemic syndrome (including Moschcowitz Syndrome), multi-system disease---other (not mentioned above), tubular necrosis (irreversible) or cortical necrosis (different from 88), tuberculosis, gout, nephrocalcinosis and hypercalcaemic nephropathy, Balkan nephropathy, kidney tumour, traumatic or surgical loss of kidney, other identified renal disorders.
